Sec. 104. Global COVID–19 vaccine distribution and delivery
348 words·~2 min read·
/bill/117/s/2297/rs/section-104A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of State, in consultation with the Secretary of Health and Human Services, the Administrator of the United States Agency for International Development, the Chief Executive Officer of the United States International Development Finance Corporation, and the heads of other relevant Federal departments and agencies, as determined by the President, shall develop a strategy to expand access to, and accelerate the global distribution of, COVID–19 vaccines to other countries, which shall— identify the countries that have the highest infection and death rates due to COVID–19, the lowest COVID–19 vaccination rates, and face the most difficult, political, logistical, and financial challenges to obtaining and delivering COVID–19 vaccines, and describe the basis and metrics used to make such determinations; identify which countries and regions will be prioritized and targeted for COVID–19 vaccine delivery, and the rationale for such prioritization; describe efforts that the United States is making to increase COVID–19 vaccine manufacturing capacity, including through the provision of development finance, and estimate when, how many, and which types of vaccines will be provided by the United States Government bilaterally and through COVAX; describe efforts to encourage international partners to take actions similar to the efforts referred to in paragraph (3); describe how the United States Government will ensure efficient delivery of COVID–19 vaccines to intended recipients, including United States citizens residing overseas, and identify complementary United States foreign assistance that will facilitate vaccine readiness, distribution, delivery, monitoring, and administration activities; describe the roles, responsibilities, tasks, and, as appropriate, the authorities of the Secretary of State, the Administrator of the United States Agency for International Development, the Secretary of Health and Human Services, the Chief Executive Officer of the United States International Development Finance Corporation, and the heads of other relevant Federal departments and agencies with respect to the implementation of such strategy; and summarize the United States public diplomacy strategies for branding and addressing vaccine misinformation and hesitancy.
Not later than 90 days after the date of the enactment of this Act, the Secretary of State shall submit the strategy described in subsection
(a)to the appropriate congressional committees.